Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering ...

During differentiation, immature cells express specific genes for different specialized function ... in immunotherapy by reprogramming types of white blood cells called T-lymphocytes to target cancer ...

Continuing our series, Dr Andrew Whittamore debunks some common myths about asthma – and explains some less well-known facts ...

During a live event, Marc S. Hoffmann, MD, discussed outcomes from the SEQUOIA and ELEVATE-TN studies in chronic lymphocytic ...

This small branch played a big role in advancing evidence-based genetic testing, and its loss diminishes US leadership in ...

Learn how breathing strategies and cold immersion techniques developed by Wim Hof directly impact the autonomic and ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

This important work presents a stochastic branching process model of tumour-immune coevolution, incorporating stochastic antigenic mutation accumulation and escape within the cancer cell population.